GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MEDITERA TIBBI MALZEME SANAYI VE TICARET AS (IST:MEDTR) » Definitions » Financial Strength

MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Financial Strength : 9 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is MEDITERA TIBBI MALZEMENAYI VE TICARET AS Financial Strength?

MEDITERA TIBBI MALZEMENAYI VE TICARET AS has the Financial Strength Rank of 9. It shows strong financial strength and is unlikely to fall into distressed situations.

Good Sign:

MEDITERA TIBBI MALZEME SANAYI VE TICARET AS shows strong financial strength.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Coverage for the quarter that ended in Mar. 2025 was 1.47. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's debt to revenue ratio for the quarter that ended in Mar. 2025 was 0.02. As of today, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Altman Z-Score is 4.97.


Competitive Comparison of MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Financial Strength

For the Medical Devices subindustry, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Financial Strength Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Financial Strength distribution charts can be found below:

* The bar in red indicates where MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Financial Strength falls into.


;
;

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Expense for the months ended in Mar. 2025 was ₺-19 Mil. Its Operating Income for the months ended in Mar. 2025 was ₺29 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₺14 Mil.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Coverage for the quarter that ended in Mar. 2025 is

Interest Coverage=-1*Operating Income (Q: Mar. 2025 )/Interest Expense (Q: Mar. 2025 )
=-1*28.505/-19.408
=1.47

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Debt to Revenue Ratio for the quarter that ended in Mar. 2025 is

Debt to Revenue Ratio=Total Debt (Q: Mar. 2025 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(27.407 + 13.645) / 2401.4
=0.02

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS has a Z-score of 4.97, indicating it is in Safe Zones. This implies the Z-Score is strong.

Good Sign:

Altman Z-score of 4.97 is strong.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS  (IST:MEDTR) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS has the Financial Strength Rank of 9. It shows strong financial strength and is unlikely to fall into distressed situations.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS Financial Strength Related Terms

Thank you for viewing the detailed overview of MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description

Traded in Other Exchanges
N/A
Address
Sokak No: 29 Tire Organize Sanayi, Ibni Melek OSB Mahallesi, TOSBI Yol 4, Bolgesi Tire, Izmir, TUR, 35900
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Headlines

No Headlines